Isolation and Characterization of Monoclonal Antibodies Which Neutralize Human Metapneumovirus In Vitro and In Vivo

Nancy D. Ulbrandt, Hong Ji, Nita Patel, +21

Journal of Virology

VaccinationViral EvolutionRespiratory Virus ImmunityAllergyViral Diagnostics +11

HIV-1 Vpr Induces Cell Cycle G2 Arrest in Fission Yeast (Schizosaccharomyces pombe) through a Pathway Involving Regulatory and Catalytic Subunits of PP2A and Acting on Both Wee1 and Cdc25

Robert T. Elder, Min Yu, Mingzhong Chen, +3

Virology

Fission YeastCell DivisionMolecular RegulationMedicineNatural Sciences +10

A gold nanoparticle-based fluorescence sensor for high sensitive and selective detection of thiols in living cells

Jian Xu, Hui Yu, Yue Hu, +2

Biosensors and Bioelectronics

EngineeringMetal NanoparticlesNanobiotechnologyBiomedical EngineeringBiosensors +5

Mutational Analysis of Vpr-Induced G ₂ Arrest, Nuclear Localization, and Cell Death in Fission Yeast

Mingzhong Chen, Robert T. Elder, Min Yu, +5

Journal of Virology

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

Tracy J. Ruckwardt, Kaitlyn M. Morabito, Emily Phung, +76

The Lancet Respiratory Medicine

VaccinationVaccine SafetyVaccine DevelopmentImmunologyVirology +4

Pleiotropic Effects of HIV-1 Protein R (Vpr) on Morphogenesis and Cell Survival in Fission Yeast and Antagonism by Pentoxifylline

Yuqi Zhao, Min Yu, Mingzhong Chen, +3

Virology

Viral ReplicationFission YeastHiv-1 Protein RHuman RetrovirusPathogenesis +10

Quantification of Human Immunodeficiency Virus Type 1 Proviral DNA by Using TaqMan Technology

Yuqi Zhao, Min Yu, Johann W. Miller, +4

Journal of Clinical Microbiology

Fission Yeast Expression Vectors Adapted for Positive Identification of Gene Insertion and Green Fluorescent Protein Fusion

Yuqi Zhao, Robert T. Elder, Mingzhong Chen, +1

BioTechniques

Viral ReplicationGeneticsMolecular BiologyGreen Fluorescent ProteinMolecular Genetics +20

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial

Kirsten E. Lyke, Andrea A. Berry, Kaitlin Mason, +97

The Lancet Infectious Diseases

Adaptive TrialMedicineMalariaImmunologyImmunotherapy +3

Functional conservation of HIV-1 Vpr and variability in a mother–child pair of long-term non-progressors

Yuqi Zhao, Mingzhong Chen, Bin Wang, +5

Virus Research

Viral PersistenceHuman RetrovirusImmunodeficienciesImmunologyAntiviral Response +10